Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease

Eur Respir J. 2024 Jan 18;63(1):2301806. doi: 10.1183/13993003.01806-2023. Print 2024 Jan.

Authors

John A Mackintosh^{1

2}, Daniel C Chambers^{3

2}

Affiliations

¹ Queensland Lung Transplant Service, Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Australia [email protected].
² School of Medicine, University of Queensland, Brisbane, Australia.
³ Queensland Lung Transplant Service, Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Australia.

PMID: 38237995
DOI: 10.1183/13993003.01806-2023

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Immunosuppression Therapy
Lung Diseases, Interstitial* / genetics
Pulmonary Fibrosis* / genetics
Telomere